| Patents for G01N 33 - Investigating or analysing materials by specific methods not covered by groups (393,632) |
|---|
| 12/13/2005 | US6974705 Method for determining the concentration of gas in a liquid |
| 12/13/2005 | US6974704 Mass spectrometric immunoassay |
| 12/13/2005 | US6974703 Electro-optical devices and methods for hybridization and detection |
| 12/13/2005 | US6974702 Fourier transform mass spectrometry of complex biological samples |
| 12/13/2005 | US6974701 disposable tubes/syringes; for vacuum withdrawal |
| 12/13/2005 | US6974700 Apparatus for detecting bacterial infections of mouth and diagnosing gum diseases; dentistry |
| 12/13/2005 | US6974699 Pharmaceuticals and assays using enzyme subunits |
| 12/13/2005 | US6974688 Nucleotide sequences coding preferential plypeptide for use in the diagnosis and treatment of hypertension, hypotension, heart disease, asthma, and the like. |
| 12/13/2005 | US6974679 Support with collagen base for tissue engineering and manufacture of biomaterials |
| 12/13/2005 | US6974675 Based on immune cells expressing specific proteins which bind to endothelioid cells of blood vessels in brain and muscle tissue in a specific protein combintion pattern; depositing a cell mixture on target cell surfaces |
| 12/13/2005 | US6974674 Predisposition to infection associated with intense exercise or other stress |
| 12/13/2005 | US6974673 Coupled capillary fiber based waveguide biosensor |
| 12/13/2005 | US6974672 Diagnosing ovavrian and colon tumors via over expression of cathepsin Z (CTSZ) and CD24 gene products; gene therapy; drug screening; antitumor agents; gene expression inhibition |
| 12/13/2005 | US6974671 Determine expression level of Potentiated GlucoCorticoid induction protein, PGC-1, or mRNA; diagnose predisposition to diabetes mellitus; drug screening |
| 12/13/2005 | US6974668 antitumor agent binds to base DNA or RNA sequence; measure cytolysis of tumor cells; drug screening |
| 12/13/2005 | US6974666 bioassay preparing libraries of diverse DNA sequences and probes for use in screening studies; molecular hybridization, splicing with nucleases and removing non-complementary sections; quantitative fluorescence analysis |
| 12/13/2005 | US6974294 Article handling system and method |
| 12/13/2005 | US6974247 Device for mixing and/or injecting cements |
| 12/13/2005 | US6973821 Compaction quality assurance based upon quantifying compactor interaction with base material |
| 12/13/2005 | US6973819 Differential compensated vapor sensor |
| 12/13/2005 | US6973706 Comprises forming channels in surfaces of the substrate, and disposing conductive material by non-impact printing to form electrode/sensor; biocompatability |
| 12/13/2005 | CA2403947C Bir domains of mammalian iap gene family |
| 12/13/2005 | CA2331699C Electrocapasitive type force measuring apparatus |
| 12/13/2005 | CA2234073C Coiled-coil heterodimer methods and compositions for the detection and purification of expressed proteins |
| 12/13/2005 | CA2193344C Immunological determination method |
| 12/13/2005 | CA2001328C Borrelia antigen |
| 12/08/2005 | WO2005117270A2 Mass spectrometry with selective ion filtration by digital thresholding |
| 12/08/2005 | WO2005116901A2 Method of diagnosing the presence and/or severity of a hepatic pathology in an individual and/or of monitoring the effectiveness of a treatment for one such pathology |
| 12/08/2005 | WO2005116662A1 Biological information detection unit |
| 12/08/2005 | WO2005116660A2 Methods for making and using mass tag standards for quantitative proteomics |
| 12/08/2005 | WO2005116659A2 Compositions and methods relating to alzheimer’s disease |
| 12/08/2005 | WO2005116658A2 Method for determining a tissue degradation process by detection of comp neoepitopes |
| 12/08/2005 | WO2005116657A2 Identification of ergothioneine transporter and therapeutic uses thereof |
| 12/08/2005 | WO2005116656A1 Identification of compounds modifying a cellular response |
| 12/08/2005 | WO2005116655A2 Natriuretic compounds, conjugates, and uses thereof |
| 12/08/2005 | WO2005116654A1 A method for detecting mycobacterial infection |
| 12/08/2005 | WO2005116653A2 Modulators of human g protein-coupled receptors for the treatment of hyperglycemia and related disorders |
| 12/08/2005 | WO2005116652A2 Method for in vitro diagnosis of sjörgen’s syndrome and lupus |
| 12/08/2005 | WO2005116651A2 Method and device for testing for bence-jones protein |
| 12/08/2005 | WO2005116650A2 High throughput discovery of materials through vapor phase synthesis |
| 12/08/2005 | WO2005116649A1 Method of screening vascular smooth muscle cell growth inhibitor and growth promoter |
| 12/08/2005 | WO2005116648A2 Method and reagent kit for evaluation of multidrug-resistance activity |
| 12/08/2005 | WO2005116647A2 System for the evaluation of tracer concentration in a reference tissue and a target region |
| 12/08/2005 | WO2005116646A1 Method for the identification of a polypeptide which binds to a given pmhc complex |
| 12/08/2005 | WO2005116645A2 Isolation of allergen-specific immunoglobulin genes from human b-cells from atopy sufferers |
| 12/08/2005 | WO2005116644A2 Method of evaluation of the relative risk of developing atherosclerosis in patients |
| 12/08/2005 | WO2005116643A2 Identification of compounds modifying a cellular response |
| 12/08/2005 | WO2005116642A2 Processing of particles |
| 12/08/2005 | WO2005116641A1 Biological sample collecting implement and method of collecting biological sample |
| 12/08/2005 | WO2005116640A2 Identification of anti-prion drugs by high-throughput screening based on sift |
| 12/08/2005 | WO2005116639A1 Method, specific primers and kit for the detection of neisseria meningitidis |
| 12/08/2005 | WO2005116638A1 Apparatus for testing a tyre and/or road surface |
| 12/08/2005 | WO2005116637A2 Apparatus and method for measuring the composition of a mixture |
| 12/08/2005 | WO2005116636A1 An apparatus and method for measuring the spectral properties of a fluid |
| 12/08/2005 | WO2005116635A1 Method for determining solubility of a chemical compound |
| 12/08/2005 | WO2005116634A1 Method probe and sensor for determination of the quality of food in particular meat |
| 12/08/2005 | WO2005116633A2 Magnetic particle resuspension probe module |
| 12/08/2005 | WO2005116632A2 Analytical systems, devices, and cartridges therefor |
| 12/08/2005 | WO2005116624A1 Highly sensitive method of detecting single nucleotide polymorphism with the use of photocurrent |
| 12/08/2005 | WO2005116623A2 Point of care heparin determination system |
| 12/08/2005 | WO2005116622A1 Connector configuration for electrochemical cells and meters for use in combination therewith |
| 12/08/2005 | WO2005116620A1 Liquid type identifying method and liquid type identifying device |
| 12/08/2005 | WO2005116618A1 Method of glass discrimination, and glass discrimination apparatus |
| 12/08/2005 | WO2005116615A1 Biosensor using whispering gallery modes in microspheres |
| 12/08/2005 | WO2005116613A2 Vial presence indicator for vial-bearing rack |
| 12/08/2005 | WO2005116611A2 Flow assay device comprising dry reagent cake |
| 12/08/2005 | WO2005116607A1 A method for the rapid analysis of polypeptides |
| 12/08/2005 | WO2005116392A1 Core analysis |
| 12/08/2005 | WO2005116378A2 Multiplexed tandem mass spectrometry |
| 12/08/2005 | WO2005116267A2 Emission ratiometric indicators of phosphorylation by c-kinase |
| 12/08/2005 | WO2005116266A2 Methods of amplifying infectious proteins |
| 12/08/2005 | WO2005116265A2 Probe arrays for expression profiling of rat genes |
| 12/08/2005 | WO2005116264A2 A blood test to monitor the genetic changes of progressive cancer using immunomagnetic enrichment and fluorescence in situ hybridization (fish) |
| 12/08/2005 | WO2005116263A2 Methods for rapid forensic analysis of mitochondrial dna |
| 12/08/2005 | WO2005116254A1 Method of quantitatively evaluating dna methylation |
| 12/08/2005 | WO2005116253A1 Probe for diagnosis of marfan’s syndrome and method of screening with the probe |
| 12/08/2005 | WO2005116244A1 Sensor arrangement comprising an electrode for detecting diffused loaded particles |
| 12/08/2005 | WO2005116242A1 Medicine safety testing method and medicine safety testing system |
| 12/08/2005 | WO2005116241A1 Method of judging properties of mammalian cell and method of diagnosing cancer |
| 12/08/2005 | WO2005116239A2 Diagnostic assays for neurodegenerative diseases |
| 12/08/2005 | WO2005116237A2 Site specific incorporation of heavy atom-containing unnatural amino acids into proteins for crystal structure determination |
| 12/08/2005 | WO2005116234A2 Detection and quantification of intracellular pathogens |
| 12/08/2005 | WO2005116219A1 Fluorescent protein |
| 12/08/2005 | WO2005116205A1 Marker genes for judging paclitaxel-sensitivity and judgment method |
| 12/08/2005 | WO2005116194A1 Method of culturing myoblst or myoblast-like cell for forming myofiber in vitro |
| 12/08/2005 | WO2005116191A1 Method of culturing embryonic stem cells with the use of amniotic membrane-origin factor |
| 12/08/2005 | WO2005116082A1 2-cysteine peroxiredoxin complex exhibiting function acting as molecular chaperone and uses thereof |
| 12/08/2005 | WO2005116080A1 Antibody specific for alkylphenol and use thereof |
| 12/08/2005 | WO2005116079A1 Antibody capable of recognizing ligand of allylhydrocarbon receptor and use thereof |
| 12/08/2005 | WO2005116074A2 Nucleoproteins displaying native t cell receptor libraries |
| 12/08/2005 | WO2005116059A1 Method of producing highly pure teicoplanin |
| 12/08/2005 | WO2005115622A1 Porous substrate plates and the use thereof |
| 12/08/2005 | WO2005115601A1 A device for controlling and regulating the physical-biochemical condition of a liquid mixture |
| 12/08/2005 | WO2005115517A2 Methods of treating diabetes |
| 12/08/2005 | WO2005115483A1 Assay for transmissible spongiform encephalopathies |
| 12/08/2005 | WO2005115478A2 Methods and compositions for autism spectrum disorders |
| 12/08/2005 | WO2005115468A1 Novel drug discovery target and medicine acting on the same |
| 12/08/2005 | WO2005115459A2 Anti-viral activity of an anti-thymidine kinase monoclonal antibody |
| 12/08/2005 | WO2005115455A2 Methods and reagents for the treatment of immunoinflammatory disorders |
| 12/08/2005 | WO2005115449A1 Method of treating allergy and infection by eliciting an iga antibody response |